Science
Mechanism of Action
Cirsium Eriophorum Callus Extract operates at a molecular level to restore skin balance. It modulates 5α-reductase, an enzyme central to sebum secretion, and Kallikrein 5, a trypsin-like serine protease involved in healthy skin exfoliation and antimicrobial response. Furthermore, it actively inhibits the overexpression of proinflammatory cytokines (IL-1α, IL-1β, IL-8, and TNF-α) in keratinocytes and increases collagen production, thereby enhancing epidermal barrier functionality.
Research
Clinical Evidence
Medium confidence0.5%
Key findings
- 01 A 4-week clinical study demonstrated that a dermo-cosmetic cream containing 0.5% Cirsium Eriophorum Callus Extract, applied twice daily, resulted in significant sebum-normalizing and pore refining activity in individuals with seborrheic or acne-prone skin. This was attributed to the regulation of 5α-reductase and Kallikrein 5, inhibition of pro-inflammatory cytokines (IL-1α, IL-1β, IL-8, TNF-α), and increased collagen synthesis.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The extract demonstrates stability within a narrow pH range of 5.4 to 5.5, as observed in a cream formulation. Its water-soluble nature simplifies integration into aqueous cosmetic bases.
Safety
Safety Profile
No specific safety assessments by CIR or SCCS have been published, and there is no specific FDA status as a cosmetic ingredient. The EWG Skin Deep database rates it with a low hazard score for various concerns (cancer, allergies, developmental toxicity), though data availability is noted as low. INCIDecoder also suggests low irritancy.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Cirsium Eriophorum Callus Extract is a valuable ingredient for precision skincare, effectively balancing sebum production, refining pores, and providing anti-inflammatory and collagen-boosting benefits, particularly for oily and sensitive skin types.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources